I don’t have any medical or investing savvy TB apart from what I have learned through my own self research / reading, and of course posts on HC now and then from the likes of yourself, Ben, Davybabyk, Hawkbar, Outlander2, Zior and a few others who provide sound reasoning and reassurance in their valued contributions. This latest post of yours is one I read with positive enthusiasm. I completely agree with your views. I too am very very confident in where this is heading. I only have 3 stocks now, having re-balanced to get rid of wasted money to put it to better use. I don’t have regrets not getting NEU, however I must admit, it is one of a top 5 I looked at a while back and inside I hold some envy for you and others who are now benefitting from it’s rise. So congrats there.
IMO, us IMU holders who have been patient will see a similar rise at some point. CF33 is such an amazing discovery IMO. I don’t think one needs to have the intellect that goes with a medical degree, or the experience of a seasoned top investor to know that Imugene, despite being a bio tech that has high risk, is a must have investment. IMO, many of us will see the benefits of our investment at some point, regardless of how long it takes. That benefit could be quite substantial and that is why it is now a large piece of my portfolio pie. So thank you for all your posts TB. I thoroughly enjoy your comments and all those from the many holders here who are themselves also confident where IMU is headed. If you do stay with HC posting I will be glad. GLTAH.
- Forums
- ASX - By Stock
- Ann: Phase 1 CF33 VAXINIA Study Update - Positive Early Signals
I don’t have any medical or investing savvy TB apart from what I...
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.8¢ |
Change
-0.001(1.04%) |
Mkt cap ! $357.0M |
Open | High | Low | Value | Volume |
4.8¢ | 4.8¢ | 4.7¢ | $277.3K | 5.790M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 4120638 | 4.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.8¢ | 933370 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 4103149 | 0.047 |
28 | 3046404 | 0.046 |
30 | 3895754 | 0.045 |
38 | 6395083 | 0.044 |
29 | 3236809 | 0.043 |
Price($) | Vol. | No. |
---|---|---|
0.048 | 931827 | 8 |
0.049 | 3553297 | 14 |
0.050 | 6898048 | 25 |
0.051 | 2641049 | 15 |
0.052 | 1856295 | 13 |
Last trade - 11.35am 12/11/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online